Compare PRCH & ATRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PRCH | ATRC |
|---|---|---|
| Founded | 2012 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.7B |
| IPO Year | 2019 | 2005 |
| Metric | PRCH | ATRC |
|---|---|---|
| Price | $12.51 | $39.68 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 7 |
| Target Price | $18.63 | ★ $51.17 |
| AVG Volume (30 Days) | ★ 1.7M | 965.1K |
| Earning Date | 04-28-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 90.91 | 74.74 |
| EPS | N/A | ★ 0.18 |
| Revenue | ★ $482,414,000.00 | $201,630,000.00 |
| Revenue This Year | $4.15 | $15.27 |
| Revenue Next Year | $17.05 | $12.21 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 10.18 | ★ 15.40 |
| 52 Week Low | $6.36 | $25.36 |
| 52 Week High | $19.44 | $43.18 |
| Indicator | PRCH | ATRC |
|---|---|---|
| Relative Strength Index (RSI) | 47.01 | 75.39 |
| Support Level | $9.08 | $39.40 |
| Resistance Level | $16.47 | $42.89 |
| Average True Range (ATR) | 0.71 | 1.47 |
| MACD | -0.33 | 0.28 |
| Stochastic Oscillator | 26.25 | 98.56 |
Porch Group Inc is a vertical software company reinventing the home services and insurance industries. It has four reportable segments: Insurance Services, Software & Data, Consumer Services, and Corporate. The majority of revenue is from the Insurance segment. The Insurance Services segment manages and operates the Reciprocal, providing services related, but not limited, to underwriting, policy renewal, risk management, insurance portfolio management, financial management, and setting investment guidelines in exchange for commissions and fees.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation, Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.